| scholarly article | Q13442814 |
| P50 | author | Mohamed A Tawfik | Q91337559 |
| Mona Mohamed Watany | Q61142790 | ||
| P2093 | author name string | Amal Selim | |
| Mohamed A Elsebaey | |||
| Maha M Hagras | |||
| Samah A Elshweikh | |||
| Hossam Hodeib | |||
| Dina Abdelhai | |||
| P2860 | cites work | The Role of Galectin-3 in the Kidneys | Q26752754 |
| Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex | Q28577438 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus | Q30426632 | ||
| Dynamics of galectin-3 in the nucleus and cytoplasm | Q33625906 | ||
| The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens. | Q33760199 | ||
| Galectin-3--a jack-of-all-trades in cancer | Q34221519 | ||
| Diabetic nephropathy: diagnosis, prevention, and treatment | Q34379284 | ||
| Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies | Q36003071 | ||
| Temporal trends in the prevalence of diabetic kidney disease in the United States | Q37064114 | ||
| Prevalence and Management of Diabetic Nephropathy in Western Countries | Q37069905 | ||
| The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. | Q37078185 | ||
| Elevated galectin-3 precedes the development of CKD | Q37119904 | ||
| Galectin-3 in diabetic patients | Q38221153 | ||
| Functions of galectin-3 and its role in fibrotic diseases | Q38246458 | ||
| Galectin-3: an emerging all-out player in metabolic disorders and their complications | Q38258947 | ||
| Galectin-3 in autoimmunity and autoimmune diseases | Q38542678 | ||
| Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander | Q38831547 | ||
| Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease | Q38945365 | ||
| Diabetic Kidney Disease: Challenges, Progress, and Possibilities | Q40206755 | ||
| Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus | Q50126684 | ||
| Predictive value of plasma galectin-3 in patients with chronic heart failure. | Q51005416 | ||
| Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor? | Q51311008 | ||
| Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study | Q74181586 | ||
| Galectin-3-positive cell infiltration in human diabetic nephropathy | Q75434736 | ||
| Is galectin-3 associated with urinary albumin excretion in type 2 diabetes? | Q87307763 | ||
| 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019 | Q90595532 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| diabetic nephropathy | Q1129105 | ||
| microalbuminuria | Q1676817 | ||
| P304 | page(s) | 325-331 | |
| P577 | publication date | 2019-03-13 | |
| P1433 | published in | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Q5270108 |
| P1476 | title | Galectin-3 as a prognostic biomarker for diabetic nephropathy | |
| P478 | volume | 12 |
| Q90515053 | Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum Galectin-3 level | cites work | P2860 |
Search more.